🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join our new lab at #Stanford as computational biologist/biostatistician to develop methods for analyzing, integrating, and visualizing quantitative proteomics data: careersearch.stanford.edu/jobs/senior-bi…. Please RT! #TeamMassSpec

Amazing tool.. will be very useful for those that want to cut through the complexity of phosphoproteomic data to get proper biological insight!

Join us for this exciting project, DM Or email if you have any questions :)

Are you finishing your PhD within the next year and are looking for an exciting postdoc project? Are you interested in applying/developing the latest AI technologies to a problem with a direct impact to health? Join us in this collaboration between EMBL-EBI and AstraZenecaUK !

Thank you to everyone who helped us run this week's #systemsbiology course; and to the amazing participants who made it such an engaging week! Want to join the 2024 edition of the course? Sign up for alerts and be the first to hear as it develops: mailchi.mp/ebi/sys24_aler…

1) According to the The Royal Society, around 61% of postdocs are non U.K. nationals. 2) postdoc starting salaries are around £36k. 3) the last significant announcement from the Government about science policy was: ‘KICKING WOKE IDEOLOGY out of science’

#SignallingAlliance seminar alert! Next up on March 7th Ruth Huttenhain will talk to us about spatially resolved signalling and Julio Saez-Rodriguez about systems biomedicine methods and applications. Please register interest here: forms.gle/Bv61nnHr41UXZx… and we will send you the link.

Amazing #postdoc position alert in our group EMBL-EBI! Funded by Open Targets , collaboration with the Garnett Lab Wellcome Sanger Institute and industry partners. We have produced the largest dataset to date of dual CRISPR perturbations (65K pairs, 45 cell lines, 2 tissue types) and are

🧵 Excited to share our latest work: scPCA — a flexible factorization model for single-cell data that integrates both cellular heterogeneity and experimental condition effects! 🚀 Let's dive in! (1/9)

Nobel Prize in Physiology or Medicine: Biology Nobel Prize in Chemistry: Biology Nobel Prize in Physics: Sounds like Biology #NobelPrize

Excited for our opening computational cancer seminar of the year by Jasmin Fisher next week- “Digital Cancer Twins: From Mechanistic Insights to Therapeutic Applications”! Tuesday 12-1 at the LMCB 2nd floor seminar room in UCL. Register below! eventbrite.co.uk/e/ucl-computat…

We are proud to present "ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma" led by Charlie Barker Sumana Sharma in collaboration with EPIC-XS Utrecht, Protavio Ltd Wellcome Sanger Institute and UofAthens biorxiv.org/content/10.110…

New preprint out! 🚨 Sumana Sharma, Evangelia Petsalaki & I explored the surprising effects of ARID1A KO in melanoma using network-based multi-omics. Interesting findings on signaling & drug resistance! Check Evangelia Petsalaki's tweetorial or read here: biorxiv.org/content/10.110…

ARID1A reshapes the resistance landscape in melanoma 🧬🔬: transcriptional rewiring alters signaling, immune interactions, and receptor dynamics, unveiling potential targets like JUN for combinatorial therapies. #Melanoma #CancerBiology #DrugResistance qeios.com/read/LCFHDG

thanks!!

New preprint from our group EMBL-EBI and the TVPLab ! We combined pseudotemporal ordering of cross sectional MASLD patient data with network analysis to describe the disease progression and identify a signature of 24 plasma biomarkers for patient staging biorxiv.org/content/10.110…

Kinases play a crucial role in many diseases, making them prime targets for therapeutic intervention. Enter PhosX, a new tool transforming the way researchers analyse and interpret kinase activity. Read the full article👇: academic.oup.com/bioinformatics… Alessandro Lussana 🇺🇦 Evangelia Petsalaki

Our study reconfigures our understanding of the mechanism cells use regulate gene expression. Previously reported to have little global impact, we report Protein degradation explains up to half of the variation in how protein levels are controlled. shorturl.at/5wPiS